Arcus Biosciences
RCUS
RCUS
173 hedge funds and large institutions have $1.33B invested in Arcus Biosciences in 2022 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 64 increasing their positions, 32 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
+16
Holders Change %
+10.19%
% of All Funds
2.93%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.08%
New
53
Increased
64
Reduced
32
Closed
35
Calls
$17.6M
Puts
$28.9M
Net Calls
-$11.3M
Net Calls Change
-$23.6M
Top Buyers
| 1 |
1
BlackRock
New York
|
$206M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$112M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$109M |
| 4 |
4
Goldman Sachs
New York
|
$24.7M |
| 5 |
FC
5
Finepoint Capital
Boston,
Massachusetts
|
$13.6M |
